The mechanism leading to the cholesterol ester accumulation downstream of the PTEN loss, which is characteristic of prostate cancer cells, involves, according to this study, the PI3K/AKT/mTOR pathway. The gene discussed is AKT1; the disease is prostate carcinoma.